Can phage therapy answer the booming antibiotic resistance problem?
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective…
Diving into the intricacies of the current trends and challenges of the biotech industry.
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective…
Synthetic biology has made it easier than ever to engineer organisms to serve our needs.…
China’s vaccine developer MaxHealth Biotechnology raised the biggest private biotech investment in the Asia-Pacific region…
The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with…
Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic…
The asthma specialist Areteia Therapeutics took the U.S.’ top private biotech investment crown in July…
Vaccines for COVID-19 have saved lives all over the world, but their protection is threatened…
Until recently, cancer detection depended on invasive solid tissue sampling that didn’t provide a complete…
Preserving Earth’s biodiversity is crucial as we rely on healthy ecosystems for many services, from…
The first RNA interference (RNAi) therapy was approved in 2018, after 20 years in development.…
The lab automation player MegaRobo stole the show in the Asia-Pacific region in June with…
Biotech companies are leveraging the wealth of omics and imaging data to study deep phenotypes…